OGG1 and T-cell non-Hodgkin lymphoma: One DMBDD-treated female Ogg1+/+ mouse developed T cell lymphoma, likely due to the MNU treatment, as previously reported in C57Bl/6J mice [39], but in our study no such thymic lymphomas were observed in Ogg1−/− mice.